Abstract
Acute severe asthma is characterized by a state of airway inflammation and increased bronchiolar smoothmuscle tone that leads to increased resistance to expiration and lung hyperinflation. Despite the better knowledge of its pathophysiology, the incidence and severity of asthma in the last twenty years is increased worldwide, although with significant age and geographic variation. As a result, the number of patients requiring more intensive medical therapy has also increased. In the most severe cases, often referred to as near-fatal asthma, the institution of mechanical ventilation may be required. Volatile anesthetics have bronchodilator effects on the bronchial smooth muscle. The use of inhalational anesthetic agents for treatment of severe status asthmaticus has been documented in case reports, case series and small uncontrolled studies. Their use may be considered in any mechanically ventilated patients whose severe bronchospasm failed to respond to maximal medical treatment. In the present review article, we aim to provide a brief description of the physio-pathological and clinical features of acute severe asthma, and of the principles of treatment, focusing our attention on the use of the inhalational anesthetics in severe patients requiring mechanical ventilation and not responding to conventional therapy.
Keywords: Status asthmaticus, near-fatal asthma, inhalational anesthetics, halothane, isoflurane, sevoflurane
Current Drug Targets
Title: Inhalational Anesthetics in Acute Severe Asthma
Volume: 10 Issue: 9
Author(s): R. Vaschetto, E. Bellotti, E. Turucz, C. Gregoretti, F. Della Corte and P. Navalesi
Affiliation:
Keywords: Status asthmaticus, near-fatal asthma, inhalational anesthetics, halothane, isoflurane, sevoflurane
Abstract: Acute severe asthma is characterized by a state of airway inflammation and increased bronchiolar smoothmuscle tone that leads to increased resistance to expiration and lung hyperinflation. Despite the better knowledge of its pathophysiology, the incidence and severity of asthma in the last twenty years is increased worldwide, although with significant age and geographic variation. As a result, the number of patients requiring more intensive medical therapy has also increased. In the most severe cases, often referred to as near-fatal asthma, the institution of mechanical ventilation may be required. Volatile anesthetics have bronchodilator effects on the bronchial smooth muscle. The use of inhalational anesthetic agents for treatment of severe status asthmaticus has been documented in case reports, case series and small uncontrolled studies. Their use may be considered in any mechanically ventilated patients whose severe bronchospasm failed to respond to maximal medical treatment. In the present review article, we aim to provide a brief description of the physio-pathological and clinical features of acute severe asthma, and of the principles of treatment, focusing our attention on the use of the inhalational anesthetics in severe patients requiring mechanical ventilation and not responding to conventional therapy.
Export Options
About this article
Cite this article as:
Vaschetto R., Bellotti E., Turucz E., Gregoretti C., Corte Della F. and Navalesi P., Inhalational Anesthetics in Acute Severe Asthma, Current Drug Targets 2009; 10 (9) . https://dx.doi.org/10.2174/138945009789108747
DOI https://dx.doi.org/10.2174/138945009789108747 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Creating Chemical Diversity to Target Protein Kinases
Combinatorial Chemistry & High Throughput Screening Current Status and Future Prospects for Research on Tyrosine Sulfation
Current Pharmaceutical Biotechnology Agents Targeting Ras Signaling Pathway
Current Pharmaceutical Design Diagnosis, Prevention and Treatment of Aspirin-Induced Asthma and Rhinitis
Current Drug Targets - Inflammation & Allergy Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Dietary Salt and Disease Prevention: A Global Perspective
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Bipolar Affective Disorder in Young People: A Review
Adolescent Psychiatry Nutrapharmacology of Tocotrienols for Metabolic Syndrome
Current Pharmaceutical Design New Insights for Multifactorial Disease Therapy: The Challenge of the Symbiotic Drugs
Current Drug Therapy Editorial : (Thematic issue: Critical Appraisal of Ischemic Stroke Pathophysiology: Road to Cerebral Resuscitation? Part II)
Current Medicinal Chemistry Ureas: Applications in Drug Design
Current Medicinal Chemistry Is There a Genetic Susceptibility to Bronchopulmonary Dysplasia?
Current Respiratory Medicine Reviews Ligand-Based Peptide Design and Combinatorial Peptide Libraries to Target G Protein-Coupled Receptors
Current Pharmaceutical Design <i>Plasmodium falciparum</i> Heat Shock Protein 70 Lacks Immune Modulatory Activity
Protein & Peptide Letters Tumor Necrosis Factor Inhibitors from Poxviruses with An Emphasis on Tanapoxvirus-2L Protein
Recent Patents on DNA & Gene Sequences Developmental Current and Future Therapy for Severe Asthma
Inflammation & Allergy - Drug Targets (Discontinued) Role of Interleukin-21 in Inflammation and Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Solid Lipid Nanoparticles as a Delivery System for Zataria multiflora Essential Oil: Formulation and Characterization
Current Drug Delivery Cellular Players in Lung Fibrosis
Current Pharmaceutical Design QSAR Studies on some Calcium Channel Blockers
Letters in Drug Design & Discovery